Verastem, Inc(NASDAQ:VSTM) 
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing medicines to enhance the life of cancer patients. Its product in development include VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibitor that ...
Website: http://www.verastem.com
Founded: 2010
Full Time Employees: 135
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 5.41
H 5.57
L 4.93
C 5.16
V 810,671
10EMA 5.16
20EMA 5.16
60EMA 5.16
120EMA 5.16
250EMA 5.16